2013
DOI: 10.1016/j.yrtph.2013.04.007
|View full text |Cite
|
Sign up to set email alerts
|

Calcium lignosulphonate: Re-evaluation of relevant endpoints to re-confirm validity and NOAEL of a 90-day feeding study in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
5
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 18 publications
2
5
0
Order By: Relevance
“…Additional evaluation of the clinical pathology data and evaluation of the animal health certificates from the regular screening programme of the performing laboratory was also done. The conclusions were published together with other study results by Thiel et al (2013).…”
Section: • Acute Toxicitysupporting
confidence: 56%
See 1 more Smart Citation
“…Additional evaluation of the clinical pathology data and evaluation of the animal health certificates from the regular screening programme of the performing laboratory was also done. The conclusions were published together with other study results by Thiel et al (2013).…”
Section: • Acute Toxicitysupporting
confidence: 56%
“…• Absorption, distribution, metabolism and elimination • Subacute, subchronic and chronic toxicity studies A 90-day feeding study in Wistar rats (Thiel et al, 2007), where calcium lignosulphonate (40-65, purity: 95.5%) was administered at doses of 0, 500, 1,000 and 2,000 mg/kg bw per day, was evaluated by the EFSA ANS Panel (2010,2011). It considered that the study to be inadequate due to the potentially impaired health status of the animals based upon a high incidence of minimal lymphoid hyperplasia in mesenteric/mandibular lymph nodes and Peyer's patches, and minimal lymphoid cell infiltration in the liver in all animals.…”
Section: Toxicological Profilementioning
confidence: 99%
“…There is no evidence from these subchronic studies, and from chronic studies with medium-and high-viscosity white mineral oils (P70A/H, P70H, P100H) (Shoda et al 1997;Trimmer et al 2004), that the MLN microgranulomas in F-344 rats progress to more a severe pathology such as inflammatory, necrotic or fibrotic lesions (Carlton et al 2001;EFSA 2012;JECFA 2012). This is supported by findings of histiocytosis in MLNs of rats orally exposed to other high molecular weight, poorly soluble materials such as calcium lignosulfonate (Thiel et al 2013), pentosan polysulphate (Abdo et al 2003), and copovidone (Mellert et al 2004). The presence of foamy histiocytes in MLNs indicate concentration-dependent (overloaded) MOSH-lipid-laden, metabolically activated macrophages which, according to the Joint FAO/WHO Expert Committee on Food Additives (JECFA 2012), do not represent an adverse effect as such.…”
Section: Effects Associated With the Accumulation Of Mosh In Animal Tmentioning
confidence: 76%
“…Therefore, the presence of substantial amount of this compound in the tissues is unlikely [11]. Furthermore, the JECFA set an acceptable daily intake of calcium lignosulfonate, based on a 90-day rat study, at a dosage up to 2,000 mg/kg body weight [19, 42]. Accordingly, such amount of calcium lignosulfonate given to rats in AXH+AFB 1 group is not possible to cause hepatotoxic.…”
Section: Discussionmentioning
confidence: 99%